BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30041953)

  • 1. Utility of routine use of breast ultrasound following contrast-enhanced spectral mammography.
    Klang E; Krosser A; Amitai MM; Sorin V; Halshtok Neiman O; Shalmon A; Gotlieb M; Sklair-Levy M
    Clin Radiol; 2018 Oct; 73(10):908.e11-908.e16. PubMed ID: 30041953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of contrast-enhanced spectral mammography (CESM) images.
    Perek S; Kiryati N; Zimmerman-Moreno G; Sklair-Levy M; Konen E; Mayer A
    Int J Comput Assist Radiol Surg; 2019 Feb; 14(2):249-257. PubMed ID: 30367322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
    Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
    Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
    Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
    Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
    Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.
    Tardivel AM; Balleyguier C; Dunant A; Delaloge S; Mazouni C; Mathieu MC; Dromain C
    Breast J; 2016 Sep; 22(5):520-8. PubMed ID: 27345656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.
    Tsigginou A; Gkali C; Chalazonitis A; Feida E; Vlachos DE; Zagouri F; Rellias I; Dimitrakakis C
    Br J Radiol; 2016 Nov; 89(1067):20160397. PubMed ID: 27452266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of suspicious calcification in the diagnosis and surgical treatment of breast lesions using contrast-enhanced spectral mammography].
    Sun XF; Xing W; Yu SN; Sha YY; Pan L; Chen Q
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(1):42-46. PubMed ID: 31914557
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
    Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
    Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced spectral mammography (CESM) in women presenting with palpable breast findings.
    Sorin V; Faermann R; Yagil Y; Shalmon A; Gotlieb M; Halshtok-Neiman O; Ben-David MA; Sklair-Levy M
    Clin Imaging; 2020 May; 61():99-105. PubMed ID: 32014818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
    Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
    Liew ALF; Lim HMY; Fok ECM; Loke SC; Tan EY; Chong BK; Lee YS; Chan PMY; Chotai N
    Breast J; 2022; 2022():7087408. PubMed ID: 35711887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts.
    Lu Z; Hao C; Pan Y; Mao N; Wang X; Yin X
    Korean J Radiol; 2020 Apr; 21(4):442-449. PubMed ID: 32193892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results.
    Łuczyńska E; Niemiec J; Hendrick E; Heinze S; Jaszczyński J; Jakubowicz J; Sas-Korczyńska B; Rys J
    Med Sci Monit; 2016 Oct; 22():3886-3893. PubMed ID: 27768681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between second-look ultrasound and second-look digital breast tomosynthesis in the detection of additional lesions with presurgical CESM.
    Bellini C; Bicchierai G; Amato F; Savi E; De Benedetto D; Di Naro F; Boeri C; Vanzi E; Miele V; Nori J
    Br J Radiol; 2022 Jun; 95(1134):20210927. PubMed ID: 35451312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI.
    Daniaux M; Gruber L; De Zordo T; Geiger-Gritsch S; Amort B; Santner W; Egle D; Baltzer PAT
    Eur J Radiol; 2023 Jun; 163():110838. PubMed ID: 37080064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of contrast-enhanced spectral mammogram (CESM) and three-dimensional breast ultrasound (3DUS) on the characterization of the disease extend in cancer patients.
    Helal MH; Mansour SM; Salaleldin LA; Alkalaawy BM; Salem DS; Mokhtar NM
    Br J Radiol; 2018 Jul; 91(1087):20170977. PubMed ID: 29641226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.